ASPN and metabolic disease: We demonstrated that PLAP-1 is expressed not only in PDL tissue but also in adipose tissue (Fig. 1A) and that it regulates the development of HFD-induced metabolic disorder and alveolar bone resorption (Figs. 2 and 3).